Clinical outcomes of kinematically aligned medial pivot total knee arthroplasty: A systematic review and meta-analysis of current evidence

运动学对线内侧枢轴全膝关节置换术的临床结果:现有证据的系统评价和荟萃分析

阅读:1

Abstract

PURPOSE: Kinematic alignment (KA) in total knee arthroplasty (TKA) focuses on restoring the natural joint line and ligament balance, potentially improving biomechanics and outcomes over mechanical alignment (MA). The medial pivot (MP) implant enhances joint stability by mimicking physiological knee motion. Still, its role within a KA protocol and the effects of retaining versus sacrificing the posterior cruciate ligament (PCL) are unclear. This study aimed to evaluate the clinical effectiveness, functional outcomes and biomechanical benefits of KA-TKA with MP implants based on the available literature. It also aimed to assess whether PCL retention or sacrifice leads to better postoperative function. METHODS: A systematic review and meta-analysis were conducted following PRISMA guidelines. A comprehensive search of PubMed, Embase and Web of Science up to January 2025 identified studies assessing KA-TKA with MP implants. Primary outcomes included patient-reported outcome measures (PROMs), range of motion (ROM), complication rates and implant survivorship. Subgroup analysis compared PCL retention and sacrifice. RESULTS: Fourteen studies (955 patients) met inclusion criteria. KA-TKA with MP implants resulted in significant ROM improvements (+11.35°, increased to +12.50° after sensitivity analysis) and enhanced PROMs (Oxford Knee Score +18.23, increased to +22.27 after sensitivity analysis; Knee Society Score [KSS] +49.61, functional KSS +42.50). No aseptic loosening or implant failures were reported. PCL sacrifice was associated with greater postoperative flexion (125.4° ± 12.1° vs. 116.4° ± 11.8°, p < 0.001), but functional outcomes were comparable. CONCLUSIONS: KA-TKA with MP implants improves functional recovery, patient satisfaction, and short- to mid-term survivorship, supporting its adoption as a viable alternative to conventional TKA. Further long-term, randomized trials are needed to optimize PCL management and confirm its durability. LEVEL OF EVIDENCE: Level IV.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。